Grifols 2023 Annual Report on Form 20-F filed with the SEC

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper

Grifols Plans First Bond Sale Since Short Seller Attack

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Grifols’ Financials Have No Big Errors, Spanish Regulator Says

Health Care Roundup: Market Talk

UPDATE 2-Europe's STOXX 600 logs weekly gains, US jobs data in focus

Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct